about
Novel insights into miRNA in lung and heart inflammatory diseasesmicroRNA in the development of diabetic complications.HypoxamiR regulation and function in ischemic cardiovascular diseases.MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex.RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions.Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceTherapeutic use of microRNAs in myocardial diseases.Neurogenic hypertension: revelations from genome-wide gene expression profiling.MicroRNAs and human diseases: diagnostic and therapeutic potential.Application of microRNAs in diagnosis and treatment of cardiovascular disease.Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methodsOverexpression of miRNA-9 Generates Muscle Hypercontraction Through Translational Repression of Troponin-T in Drosophila melanogaster Indirect Flight MusclesDefining miRNA targets: balancing simplicity with complexity.Distinct microRNA expression signatures in human right atrial and ventricular myocardium.
P2860
Q27026348-0718D529-1055-4EB1-8EE4-BFBAF3929569Q30353835-AD9A96E4-5459-4577-8BCD-24668483D45FQ34082010-FDC45773-4814-4485-B160-972D77FA5420Q34097829-0F830401-DD09-41A4-8D88-5E7BD31920B0Q34257330-C5975B87-A4DB-44D7-8C68-CF54A9BC2F2FQ34542113-2CF25DB0-1177-4926-9482-ABECC2ACD384Q35108974-1216E850-3D34-4B3D-AD17-A3D64542CBD5Q35643799-7D4E387B-2244-40D6-BA29-6E7E0C7AAEF0Q36364300-3CD34C46-454B-4A27-99D3-F7533437279BQ37895538-0DEC0743-3E0A-4CF1-B196-3DEB027E32EAQ38013692-B895533F-2725-4EDB-A574-FE998300BE6FQ38184973-AA93636C-55BD-4A7D-A5AF-98F02DDB17AAQ38264294-19BCBDC9-59CB-4C40-8BBB-D905844B4E9EQ39093828-E5D28F19-7B10-4AA7-947D-8C024965D723Q41464923-2777208D-A122-410E-B0B5-25033180F3A6Q42373250-78A5E04E-F6F9-447E-8B92-14B04629EA50Q42566820-B55EC551-2A26-4C78-A7D0-7E7DEFB9FB8AQ46146502-43F78351-6C7E-41E0-B965-D7A595EB9774
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
microRNAs in hypertrophy and heart failure.
@en
microRNAs in hypertrophy and heart failure.
@nl
type
label
microRNAs in hypertrophy and heart failure.
@en
microRNAs in hypertrophy and heart failure.
@nl
prefLabel
microRNAs in hypertrophy and heart failure.
@en
microRNAs in hypertrophy and heart failure.
@nl
P2860
P356
P1476
microRNAs in hypertrophy and heart failure.
@en
P2093
Michael V G Latronico
P2860
P304
P356
10.1258/EBM.2010.010269
P577
2011-02-01T00:00:00Z